1443421-68-8Abacavir EP Impurity F
● Auf Lager
| Katalog-Nr.:: | VL760003 |
|---|---|
| CAS-Nr.:: | 1443421-68-8 |
| Summenformel:: | C18H26N6O |
| Molare Masse:: | 342.44 g/mol |
Zusätzliche Informationen zu CAS 1443421-68-8
Parent drug
AbacavirIUPAC-Name
6-(Cyclopropylamino)-9-[(1R,4S)-4-[[(1,1-dimethylethyl)oxy]methyl]cyclopent-2-enyl]-9H-purine-2-aminePharmakopöe-Synonyme
T-Butyl Derivative AbacavirOther Synonyms
O-t-Butyl Derivative Abacavir; Abacavir t-Butyl Ether; 9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-enyl)-N6-cyclopropyl-9H-purine-2,6-diamine; N6-Cyclopropyl-9-[(1R,4S)-4-[(1,1-dimethylethoxy)methyl]-2-cyclopenten-1-yl]-9H-purine-2,6-diamine; 9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-en-1-yl)-N6-cyclopropyl-9H-purine-2,6-diamine; 6-N-cyclopropyl-9-[(1R,4S)-4-[(2-methylpropan-2-yl)oxymethyl]cyclopent-2-en-1-yl]purine-2,6-diamine; 9-[(1R,4S)-4-(tert-butoxymethyl)cyclopent-2-en-1-yl]-N6-cyclopropylpurine-2,6-diamineBeschreibung
Abacavir EP Impurity F(CAS No: 1443421-68-8) or T-Butyl Derivative Abacavir is an impurity formed by the degradation of Abacavir that is a nucleoside reverse transcriptase inhibitor utilized in the treatment of human immunodeficiency virus infection, and mainly helps to obstruct the inroads of the human immunodeficiency virus.References
Vukkum, Pallavi. “Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, Its Related Substances, and Degradation Products.” Scientia Pharmaceutica, vol. 80, no. 4, 2012, pp. 903–21, https://doi.org/10.3797/scipharm.1206-11.Angebot anfordern
„*“ zeigt erforderliche Felder an









